A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today with ...

Bioanalysis is also used to monitor therapeutic responses by evaluating drug levels, biomarkers, and physiological changes ...

Through a series of position papers, the EFPIA representing brandname drugmakers, self-medication group organisation AESGP, ...

In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...

Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...

According to the paper by researchers at the University of Bath in the UK and Lund University in Sweden, the self-regulated ...

In conclusion, I see 2025 as a year in which the patient will still be centre-stage. But, in order for that to happen ...

This tiered approach allows investors to engage at the level they’re most comfortable with, sparking their interest with a ...

The UK's Poolbeg Pharma has disclosed that it is in talks over a possible takeover by Hookipa, an Austrian biotech that is listed on the Nasdaq.

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...

As pharmaceutical companies increasingly rely on artificial intelligence (AI) to optimise trial processes, the potential for AI models to drift over time poses significant risks to trial integrity ...